法律授权紧急医疗服务机构增加美沙酮治疗阿片类药物使用障碍的机会。
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
机构信息
Harm Reduction Legal Project, Network for Public Health Law, Los Angeles, CA.
ChangeLab Solutions, Oakland, CA.
出版信息
Ann Emerg Med. 2021 Jul;78(1):102-108. doi: 10.1016/j.annemergmed.2021.01.017. Epub 2021 Mar 27.
Abstract
Treatment with buprenorphine significantly reduces both all-cause and overdose mortality among individuals with opioid use disorder. Offering buprenorphine treatment to individuals who experience a nonfatal opioid overdose represents an opportunity to reduce opioid overdose fatalities. Although some emergency departments (EDs) initiate buprenorphine treatment, many individuals who experience an overdose either refuse transport to the ED or are transported to an ED that does not offer buprenorphine. Emergency medical services (EMS) professionals can help address this treatment gap. In this Concepts article, we describe the federal legal landscape that governs the ability of EMS professionals to administer buprenorphine treatment, and discuss state and local regulatory considerations relevant to this promising and emerging practice.
摘要
丁丙诺啡治疗可显著降低阿片类药物使用障碍患者的全因死亡率和过量死亡率。为经历非致命性阿片类药物过量的个体提供丁丙诺啡治疗，是减少阿片类药物过量死亡的一个机会。尽管一些急诊科 (ED) 开始使用丁丙诺啡治疗，但许多经历过量的个体要么拒绝被送往 ED，要么被送往不提供丁丙诺啡的 ED。紧急医疗服务 (EMS) 专业人员可以帮助解决这一治疗缺口。在这篇概念文章中，我们描述了管理 EMS 专业人员管理丁丙诺啡治疗能力的联邦法律环境，并讨论了与这一有前途和新兴实践相关的州和地方监管考虑因素。
相似文献
1
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.法律授权紧急医疗服务机构增加美沙酮治疗阿片类药物使用障碍的机会。
Ann Emerg Med. 2021 Jul;78(1):102-108. doi: 10.1016/j.annemergmed.2021.01.017. Epub 2021 Mar 27.
2
Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation.通过急救人员在现场起始丁丙诺啡为阿片类药物过量后治疗提供通往门诊治疗服务的桥梁。
J Subst Use Addict Treat. 2024 Jul;162:209364. doi: 10.1016/j.josat.2024.209364. Epub 2024 Apr 16.
3
Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit.急诊医疗服务与门诊药物使用障碍观察单位合作，促进阿片类药物过量后长效丁丙诺啡的起始治疗。
Subst Use Addctn J. 2024 Oct;45(4):771-776. doi: 10.1177/29767342241249386. Epub 2024 May 12.
4
Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.急诊科阿片类药物使用障碍丁丙诺啡的应用：现状和未来潜力。
CNS Drugs. 2019 Dec;33(12):1147-1154. doi: 10.1007/s40263-019-00667-7.
5
Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.年轻人经历非致命阿片类药物相关过量用药的特征和用药治疗情况。
Ann Emerg Med. 2020 Jan;75(1):29-38. doi: 10.1016/j.annemergmed.2019.07.030. Epub 2019 Oct 4.
6
Prehospital Initiation of Buprenorphine Treatment for Opioid Use Disorder by Paramedics.院前急救员对阿片类药物使用障碍患者实施丁丙诺啡治疗。
Prehosp Emerg Care. 2022 Nov-Dec;26(6):811-817. doi: 10.1080/10903127.2021.1977440. Epub 2021 Nov 22.
7
Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).促进急诊科启动丁丙诺啡治疗阿片类药物使用障碍的实施促进：一项混合 III 型有效性实施研究（项目 ED HEALTH）的方案。
Implement Sci. 2019 May 7;14(1):48. doi: 10.1186/s13012-019-0891-5.
8
US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.2011 - 2016年期间，美国急诊科与阿片类药物相关的就诊人数增加，而用于阿片类药物使用障碍的药物使用情况难以察觉。
J Gen Intern Med. 2020 Mar;35(3):965-966. doi: 10.1007/s11606-019-05249-3.
9
Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.远程丁丙诺啡用于急诊过量就诊的随访和治疗启动。
Am J Emerg Med. 2021 Dec;50:409-412. doi: 10.1016/j.ajem.2021.08.071. Epub 2021 Aug 28.
10
Prehospital Buprenorphine Treatment for Opioid Use Disorder by Paramedics: First Year Results of the EMS Buprenorphine Use Pilot.院前美沙酮治疗：EMS 美沙酮使用试点项目的第一年结果。
Prehosp Emerg Care. 2023;27(3):334-342. doi: 10.1080/10903127.2022.2061661. Epub 2022 May 13.
引用本文的文献
1
Predictors of non-transport by emergency medical services after a nonfatal opioid overdose: a national analysis.非致命性阿片类药物过量使用后紧急医疗服务不转运的预测因素：一项全国性分析。
Health Aff Sch. 2025 May 20;3(5):qxaf101. doi: 10.1093/haschl/qxaf101. eCollection 2025 May.
2
Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic : State Telehealth Policies and Buprenorphine.新冠疫情早期促进远程医疗与丁丙诺啡治疗起始及疗程的州政策之间的关联：州远程医疗政策与丁丙诺啡
J Gen Intern Med. 2024 Nov 14. doi: 10.1007/s11606-024-09188-6.
3
"You might be nice, but where you take me, they're not gonna be": Preferences for field-based post-overdose interventions.“你可能人很好，但你带我去的地方，他们不会这样做的”：对基于现场的中毒后干预措施的偏好。
Drug Alcohol Rev. 2024 Nov;43(7):1865-1879. doi: 10.1111/dar.13926. Epub 2024 Aug 28.
4
Antecedents of fatal overdose in an adult cohort identified through administrative record linkage in Indiana, 2015-2022.印第安纳州 2015-2022 年通过行政记录关联确定的成人队列中致命过量用药的前因。
Drug Alcohol Depend. 2023 Jun 1;247:109891. doi: 10.1016/j.drugalcdep.2023.109891. Epub 2023 Apr 22.
5
Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States.美国 COVID-19 大流行期间医疗补助扩张与药物过量死亡率。
Drug Alcohol Depend. 2022 Mar 1;232:109340. doi: 10.1016/j.drugalcdep.2022.109340. Epub 2022 Feb 2.
6
Reply to Letter to the Editor Regarding Article: "Considering the Potential Benefits of Over-The-Counter Naloxone" [Response To Letter].致编辑的关于文章《考虑非处方纳洛酮的潜在益处》的回复信[对信件的回应]。
Integr Pharm Res Pract. 2021 Jul 9;10:77-78. doi: 10.2147/IPRP.S327403. eCollection 2021.
本文引用的文献
1
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19.新冠疫情后，美国通过远程医疗持续增加丁丙诺啡的可及性。
Int J Drug Policy. 2021 Jul;93:102905. doi: 10.1016/j.drugpo.2020.102905. Epub 2020 Aug 15.
2
Variations in the California Emergency Medical Services Response to Opioid Use Disorder.加利福尼亚州紧急医疗服务机构对阿片类药物使用障碍的反应存在差异。
West J Emerg Med. 2020 Apr 16;21(3):671-676. doi: 10.5811/westjem.2019.12.45189.
3
Innovation During COVID-19: Improving Addiction Treatment Access.新冠疫情期间的创新：改善成瘾治疗的可及性。
J Addict Med. 2020 Jul/Aug;14(4):e8-e9. doi: 10.1097/ADM.0000000000000685.
4
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.美国各县种族/民族隔离与阿片类药物使用障碍治疗能力的关系。
JAMA Netw Open. 2020 Apr 1;3(4):e203711. doi: 10.1001/jamanetworkopen.2020.3711.
5
A Framework for EMS Outreach for Drug Overdose Survivors: A Case Report of the Houston Emergency Opioid Engagement System.针对药物过量幸存者的紧急医疗服务外展框架：休斯顿紧急阿片类药物参与系统的病例报告
Prehosp Emerg Care. 2021 May-Jun;25(3):441-448. doi: 10.1080/10903127.2020.1755755. Epub 2020 May 4.
6
Nonfatal Drug Overdoses Treated in Emergency Departments - United States, 2016-2017.2016-2017 年美国急诊科治疗的非致命性药物过量。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):371-376. doi: 10.15585/mmwr.mm6913a3.
7
Buprenorphine Field Initiation of ReScue Treatment by Emergency Medical Services (Bupe FIRST EMS): A Case Series.丁丙诺啡现场急救医疗服务（BupeFIRSTEMS）启动解救治疗：病例系列研究。
Prehosp Emerg Care. 2021 Mar-Apr;25(2):289-293. doi: 10.1080/10903127.2020.1747579. Epub 2020 May 4.
8
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.药物和阿片类药物相关过量死亡 - 美国，2017-2018 年。
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.
9
Opportunities for Emergency Medical Services Intervention to Prevent Opioid Overdose Mortality.紧急医疗服务干预预防阿片类药物过量致死的机会。
Prehosp Emerg Care. 2021 Mar-Apr;25(2):182-190. doi: 10.1080/10903127.2020.1740363. Epub 2020 Apr 2.
10
One-Year Mortality and Associated Factors in Patients Receiving Out-of-Hospital Naloxone for Presumed Opioid Overdose.接受院外纳洛酮治疗疑似阿片类药物过量的患者的一年死亡率及其相关因素。
Ann Emerg Med. 2020 May;75(5):559-567. doi: 10.1016/j.annemergmed.2019.11.022. Epub 2020 Jan 23.
Zotero 插件